The shares are listed on Nasdaq

Davis Polk advised the representatives of the several underwriters in connection with the follow-on offering of 11,430,000 shares of common stock of Natera, Inc. for total gross proceeds of approximately $400 million. The underwriters have been granted an option to purchase up to 1,714,500 additional shares. The shares are listed on the Nasdaq Global Select Market under the symbol “NTRA.”

Based in Austin, Texas, Natera is a diagnostics company with proprietary molecular and bioinformatics technology that it is applying to change the management of disease worldwide.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Beth LeBow, Sarah Catherine Chouinard and Dove Barbanel. Partner Frank J. Azzopardi and associate Hilary Smith provided intellectual property advice. The tax team included partner Michael Farber and associate Ted Lee. Counsel Sarah E. Kim provided ’40 Act advice. Members of the Davis Polk team are based in the Northern California and New York offices.